22 results on '"Solli, Kristin Klemmetsby"'
Search Results
2. Personal recovery among people with opioid use disorder during treatment with extended-release naltrexone
3. ‘Not at all what I had expected’: Discontinuing treatment with extended-release naltrexone (XR-NTX): A qualitative study
4. Patients’ experiences of continued treatment with extended-release naltrexone: a Norwegian qualitative study
5. Availability of Extended-Release Naltrexone May Increase the Number of Opioid-Dependent Individuals in Treatment : Extension of a Randomized Clinical Trial
6. Interest in Extended Release Naltrexone among Opioid Users
7. Characteristics of opioid-dependent patients choosing antagonist treatment with extended-release naltrexone compared with patients in opioid maintenance treatment in Norway.
8. Impact of Impulsivity, Hyperactivity, and Inattention on Discontinuation Rate among Opioid-Dependent Patients Treated with Extended-Release Naltrexone
9. Effectiveness of Injectable Extended-Release Naltrexone vs Daily Buprenorphine-Naloxone for Opioid Dependence: A Randomized Clinical Noninferiority Trial
10. Risk of Relapse to Non-Opioid Addictive Substances Among Opioid Dependent Patients Treated with an Opioid Receptor Antagonist or a Partial Agonist: A Randomized Clinical Trial
11. Levels of Impulsivity, Hyperactivity, and Inattention and the Association with Mental Health and Substance Use Severity in Opioid-Dependent Patients Seeking Treatment with Extended-Release Naltrexone
12. Risk of Relapse Among Opioid‐Dependent Patients Treated With Extended‐Release Naltrexone or Buprenorphine‐Naloxone: A Randomized Clinical Trial
13. Risk of Relapse Among Opioid‐Dependent Patients Treated With Extended‐Release Naltrexone or Buprenorphine‐Naloxone: A Randomized Clinical Trial
14. Adapting treatment length to opioid‐dependent individuals’ needs and preferences: a 2‐year follow‐up to a 1‐year study of extended‐release naltrexone
15. Discrepancy in Ratings of Shared Decision Making Between Patients and Health Professionals: A Cross Sectional Study in Mental Health Care
16. The effectiveness, safety and feasibility of extended-release naltrexone in treatment of opioid dependence: A 12-month clinical study
17. Anxiety, Depression, and Insomnia Among Adults With Opioid Dependence Treated With Extended-Release Naltrexone vs Buprenorphine-Naloxone
18. Effectiveness, safety and feasibility of extended-release naltrexone for opioid dependence: a 9-month follow-up to a 3-month randomized trial
19. Design of a randomized controlled trial of extended-release naltrexone versus daily buprenorphine-naloxone for opioid dependence in Norway (NTX-SBX)
20. Interest in Extended Release Naltrexone among Opioid Users
21. Er det bare tiden som vil vise? : En tekstanalyse av formål med bruk av tvang overfor mennesker med rusmiddelmisbruk
22. Adapting treatment length to opioid-dependent individuals' needs and preferences: A 2-year follow-up to a 1-year study of extended-release naltrexone.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.